Testing ELU42 spray for diabetic foot ulcers
Part of Heart & circulation, Hormones & metabolism, Skin clinical trials.
This study tests a new topical spray (ELU42) to help heal diabetic foot ulcers. It may be a good option if you have a non-infected, non-ischemic ulcer and your blood sugar is reasonably controlled.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have type 1 or type 2 diabetes.
- Your A1C (a measure of blood sugar control) is 10 or less.
- Your body mass index (BMI) is 36 or lower.
- You have a diabetic foot ulcer that is small to medium size (about 1 to 8 square centimeters) and has been present for 4 to 52 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new wound therapy for diabetic foot ulcers that haven't healed with standard care. It aims to see if the therapy helps these ulcers heal better and faster.
This trial tests a new wound covering called NeoThelium FT to help diabetic foot ulcers heal. It is for people whose ulcer has not improved much with standard care and is not infected or too deep.
This trial tests a new product (EDX110) to help heal diabetic foot ulcers that haven't improved with standard care. It's for people with diabetes who have a non-infected or mildly infected ulcer on their foot.
This study compares two topical (applied on the skin) antimicrobial agents—Dakin’s and Prontosan—to help heal diabetic foot ulcers. You may be eligible if you have a diabetic foot ulcer that has been present for at least 3 weeks and is large enough.
This study tests a special wound dressing made from a placental tissue (called PpLHACM) plus standard care, compared to standard care alone, to help heal diabetic foot ulcers that have not healed with usual treatment. It is for people with diabetes who have a moderate-sized foot ulcer without infection or exposed bone.
This trial tests whether adding a special treatment (cellular acellular and matrix-like products) to standard wound care helps diabetic foot ulcers and venous leg ulcers heal faster. It may be an option if you have a diabetes-related foot ulcer that hasn't healed with standard care.
Hear when a new Diabetic Foot Ulcer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.